Soll Eye Associates
Philadelphia, Pennsylvania, 19124, United States
NCT Number: NCT00595543
To compare bromfenac 0.09%, diclofenac sodium 0.1%, and ketorolac tromethamine 0.5% ophthalmic solutions for the treatment of acute pseudophakic CME after cataract surgery.
Looking for future studies?
Notify Me18 year and older
All sexes
Interventional
Phase 4
Philadelphia, Pennsylvania, 19124, United States
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
1 drop (in the eye) Instill one drop in the affected eye twice daily for three months
1 drop (in the eye) Instill one drop in the affected eye four times daily for three months
1 drop (in the eye) Instill one drop in the affected eye four times daily for three months
Time frame: 5 months
Time frame: 5 months
Bp Consulting, Inc
Network
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.